Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer

Biochemical and Biophysical Research Communications

Volumn 297, Issue 1, 2002, Pages 125-128

  Maass, Nicolai ^a   Biallek, Marco ^a   Rösel, Frank ^a   Schem, Christian ^a   Ohike, Nobuyuki ^a   Zhang, Ming ^b   Jonat, Walter ^a   Nagasaki, Koichi ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

5 AZA dC; Breast cancer; DNA methylation; Histone deacetylation; Maspin; TSA

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; HISTONE; MASPIN; SERINE PROTEINASE INHIBITOR; TRICHOSTATIN A;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; DEACETYLATION; DNA METHYLATION; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION;

ACETYLATION; BREAST NEOPLASMS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HISTONES; HUMANS; PROTEINS; SERPINS; TUMOR CELLS, CULTURED;

EID: 0036382940     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02136-8     Document Type: Article

References (23)

1. Z. Zou, A. Anisowicz, M.J. Hendrix, A. Thor, M. Neveu, S. Sheng, K. Rafidi, E. Seftor, R. Sager, Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells, Science 263 (1994) 526-529.
2. S. Sheng, P. Pemberton, R. Sager, Production, purification, and characterization of recombinant maspin proteins, J. Biol. Chem. 269 (1994) 30988-30993.
3. S. Sheng, J. Carey, E.A. Seftor, L. Dias, M.J.C. Hendrix, R. Sager, Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells, Proc. Natl. Acad. Sci. USA 93 (1996) 11669-11674.
4. M. Zhang, O. Volpert, Y.H. Shi, N. Bouck, Maspin is an angiogenesis inhibitor, Nat. Med. 6 (2000) 196-199.
5. N. Maass, T. Hojo, F. Rosel, T. Ikeda, W. Jonat, K. Nagasaki, Down-regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis, Clin. Biochem. 34 (2001) 303-307.
6. N. Maass, M. Teffner, F. Rosel, R. Pawaresch, W. Jonat, K. Nagasaki, P. Rudolph, Decline in the expression of the serine proteinase inhibitor maspin is associated with tumor progression in ductal carcinoma of the breast, J. Pathol. 195 (2001) 321-326.
7. M. Zhang, N. Maass, D. Magit, R. Sager, Transactivation through Ets and Ap1 transcriptional sites determines the expression of the tumor-suppressing gene maspin, Cell Growth Differ. 8 (1997) 179-186.
8. F.E. Domann, J.E. Rice, M.J. Hendrix, B.W. Futscher, Epigenetic silencing of maspin gene expression in human breast cancer, Int. J. Cancer 85 (2000) 805-810.
9. N. Maass, T. Hojo, M. Ueding, J. Luttges, G. Kloppel, W. Jonat, K. Nagasaki, Expression of the tumor suppressor gene maspin in human pancreatic cancers, Clin. Cancer Res. 7 (2001) 812-817.
10. P.A. Pemberton, D.T. Wong, H.L. Gibson, M.C. Kiefer, P.A. Fitzpatrick, R. Sager, P.J. Barr, The tumor suppressor maspin does not undergo the stressed to relaxed transition or inhibit trypsin-like serine proteases, J. Biol. Chem. 270 (1995) 15832-15837.
11. R. Sager, S. Sheng, P. Pemberton, M.J.C. Hendrix, Maspin. A tumor suppressing serpin, in: U. Bunthert, W. Birchmeier (Eds.), Current Topics in Microbiology and Immunology, vol. 213, Berlin, Springer, 1996, pp. 51-64.
12. M.J.C. Hendrix, E.A. Seftor, P.A. Thomas, S. Sheng, R.E.B. Seftor, Biological function(s) of maspin, Proc. Am. Assoc. Cancer Res. 38 (1997) 64.
13. J.C. Soria, H.Y. Lee, J.I. Lee, L. Wang, J.P. Issa, B.L. Kemp, D.D. Liu, J.M. Kurie, L. Mao, F.R. Khuri, Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation, Clin. Cancer Res. 8 (2002) 1178-1184.
14. H.B. Salvesen, N. MacDonald, A. Ryan, I.J. Jacobs, E.D. Lynch, L.A. Akslen, S. Das, PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma, Int. J. Cancer 91 (2001) 22-26.
15. Y. Yuan, R. Mendez, A. Sahin, J.L. Dai, Hypermethylation leads to silencing of the SYK gene in human breast cancer, Cancer Res. 61 (2001) 5558-5561.
16. A. Merlo, J.G. Herman, L. Mao, D.J. Lee, E. Gabrielson, P.C. Burger, S.B. Baylin, D. Sidransky, 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers, Nat. Med. 7 (1995) 686-692.
17. C. Stirzaker, D.S. Millar, C.L. Paul, P.M. Warnecke, J. Harrison, P.C. Vincent, M. Frommer, S.J. Clark, Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors, Cancer Res. 57 (1997) 2229-2237.
18. P.A. Wade, A. Gegonne, P.L. Jones, E. Ballestar, F. Aubry, A.P. Wolffe, Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation, Nat. Genet. 1 (1999) 62-66.
19. S. Eden, T. Hashimshony, I. Keshet, H. Cedar, A.W. Thorne, DNA methylation models histone acetylation, Nature 394 (1998) 842.
20. M.R. Rountree, K.E. Bachman, S.B. Baylin, DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci, Nat. Genet. 3 (2000) 269-277.
21. K.D. Robertson, S. Ait-Si-Ali, T. Yokochi, P.A. Wade, P.L. Jones, A.P. Wolffe, DNMT1 forms a complex with Rb, E2F1, and HDAC1 and represses transcription from E2F-responsive promoters, Nat. Genet. 3 (2000) 338-342.
22. M. Zhang, Y. Shi, D. Magit, P.A. Furth, R. Sager, Reduced mammary tumor progression in WAP-TAg/WAP-maspin bitrans-genic mice, Oncogene 19 (2000) 6053-6058.
23. H.Y. Shi, W. Zhang, R. Liang, S. Abraham, F.S. Kittrell, D. Medina, M. Zhang, Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model, Cancer Res. 61 (2001) 6945-6951.